Страна: США
мова: англійська
Джерело: NLM (National Library of Medicine)
OXYCODONE HYDROCHLORIDE (UNII: C1ENJ2TE6C) (OXYCODONE - UNII:CD35PMG570)
Physicians Total Care, Inc.
OXYCODONE HYDROCHLORIDE
OXYCODONE HYDROCHLORIDE 5 mg
ORAL
PRESCRIPTION DRUG
Oxycodone hydrochloride tablets are an immediate-release oral formulation of oxycodone hydrochloride indicated for the management of moderate to severe pain where the use of an opioid analgesic is appropriate. Oxycodone hydrochloride tablets are contraindicated in patients with known hypersensitivity to oxycodone, or in any situation where opioids are contraindicated. This includes patients with significant respiratory depression (in unmonitored settings or the absence of resuscitative equipment) and patients with acute or severe bronchial asthma or hypercarbia. Oxycodone hydrochloride tablets are contraindicated in any patient who has or is suspected of having paralytic ileus. Oxycodone hydrochloride tablets contain oxycodone, a mu-agonist opioid of the morphine type and is a Schedule II controlled substance. Oxycodone hydrochloride tablets, like other opioids used in analgesia, can be abused and is subject to criminal diversion. Drug addiction is characterized by compulsive use, use for non-medi
Oxycodone Hydrochloride Tablets, USP 5 mg: white, round, convex, scored tablets, debossed "4810" on one side and debossed "V" on the reverse side, are supplied in: bottles of 20 (NDC 54868-4983-2), bottles of 30 (NDC 54868-4983-4), bottles of 50 (NDC 54868-4983-1), bottles of 60 (NDC 54868-4983-0), bottles of 90 (NDC 54868-4983-3), bottles of 100 (NDC 54868-4983-5), bottles of 120 (NDC 54868-4983-8), bottles of 150 (NDC 54868-4983-9). 15 mg: light green, round, convex, scored tablets, debossed "4811" on one side and debossed "V" on the reverse side, are supplied in: bottles of 30 (NDC 54868-4980-2), bottles of 60 (NDC 54868-4980-0), bottles of 90 (NDC 54868-4980-3), bottles of 100 (NDC 54868-4980-4), bottles of 120 (NDC 54868-4980-1), bottles of 150 (NDC 54868-4980-5), bottles of 180 (NDC 54868-4980-6). 30 mg: light blue, round, convex, scored tablets, debossed "4812" on one side and debossed "V" on the reverse side, are supplied in: bottles of 20 (NDC 54868-5390-2), bottles of 30 (NDC 54868-5390-1), bottles of 60 (NDC 54868-5390-0), bottles of 90 (NDC 54868-5390-5), bottles of 100 (NDC 54868-5390-3), bottles of 120 (NDC 54868-5390-4), bottles of 150 (NDC 54868-5390-6), bottles of 180 (NDC 54868-5390-7), bottles of 200 (NDC 54868-5390-8). DEA Order Form Required Dispense in a tight, light-resistant container. Protect from moisture. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Manufactured for: QUALITEST PHARMACEUTICALS Huntsville, AL 35811 8181892 R4/09-R3 Relabeling and Repackaging by: Physicians Total Care, Inc. Tulsa, OK 74146
Abbreviated New Drug Application
OXYCODONE HYDROCHLORIDE - OXYCODONE HYDROCHLORIDE TABLET PHYSICIANS TOTAL CARE, INC. ---------- DESCRIPTION Oxycodone Hydrochloride Tablets, USP are opioid analgesics. Each tablet for oral administration contains 5 mg, 15 mg, or 30 mg of oxycodone hydrochloride USP. Oxycodone hydrochloride is a white, odorless crystalline powder derived from the opium alkaloid, thebaine. Oxycodone hydrochloride dissolves in water (1 g in 6 to 7 mL) and is considered slightly soluble in alcohol (octanol water partition coefficient is 0.7). Chemically, oxycodone hydrochloride is 4,5α-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6- one hydrochloride and has the following structural formula: The tablets contain the following inactive ingredients: lactose monohydrate, magnesium stearate, microcrystalline cellulose, povidone, sodium starch glycolate, stearic acid. In addition, the 15 mg and 30 mg tablets contain FD&C Blue #1 aluminum lake, and the 15 mg tablets also contain D&C Yellow #10 aluminum lake. The 5 mg, 15 mg, and 30 mg tablets contain the equivalent of 4.5 mg, 13.5 mg, and 27 mg, respectively, of oxycodone free base. CLINICAL PHARMACOLOGY Pharmacology: The analgesic ingredient, oxycodone, is a semi-synthetic narcotic with multiple actions qualitatively similar to those of morphine; the most prominent of these involves the central nervous system and organs composed of smooth muscle. Oxycodone, as the hydrochloride salt, is a pure agonist opioid whose principal therapeutic action is analgesia and has been in clinical use since 1917. Like all pure opioid agonists, there is no ceiling effect to analgesia, such as is seen with partial agonists or non-opioid analgesics. Based upon a single- dose, relative-potency study conducted in humans with cancer pain, 10 to 15 mg of oxycodone given intramuscularly produced an analgesic effect similar to 10 mg of morphine given intramuscularly. Both drugs have a 3 to 4 hour duration of action. Oxycodone retains approximately one half of its analgesic activity when administered orally. Effect Прочитайте повний документ